A detailed history of Msh Capital Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Msh Capital Advisors LLC holds 1,396 shares of LLY stock, worth $1.18 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,396
Previous 1,829 23.67%
Holding current value
$1.18 Million
Previous $593 Million 81.68%
% of portfolio
0.34%
Previous 0.28%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$727.2 - $932.06 $314,877 - $403,581
-433 Reduced 23.67%
1,396 $1.08 Billion
Q3 2024

Feb 13, 2025

SELL
$772.14 - $960.02 $40,923 - $50,881
-53 Reduced 3.54%
1,445 $1.28 Billion
Q2 2024

Feb 13, 2025

SELL
$724.87 - $909.04 $132,651 - $166,354
-183 Reduced 10.89%
1,498 $1.36 Billion
Q1 2024

Feb 13, 2025

SELL
$592.2 - $792.28 $514,029 - $687,699
-868 Reduced 34.05%
1,681 $1.31 Billion
Q4 2023

Feb 13, 2025

BUY
$525.19 - $619.13 $474,771 - $559,693
904 Added 54.95%
2,549 $1.49 Billion
Q3 2023

Feb 13, 2025

SELL
$434.7 - $599.3 $20,430 - $28,167
-47 Reduced 2.78%
1,645 $884 Million
Q2 2023

Feb 13, 2025

SELL
$350.74 - $468.98 $52,611 - $70,347
-150 Reduced 8.14%
1,692 $794 Million
Q1 2023

Feb 13, 2025

BUY
$310.63 - $364.82 $31,063 - $36,482
100 Added 5.74%
1,842 $633 Million
Q4 2022

Feb 13, 2025

SELL
$321.55 - $374.67 $27,010 - $31,472
-84 Reduced 4.6%
1,742 $637 Million
Q3 2022

Feb 13, 2025

BUY
$296.48 - $337.87 $127,486 - $145,284
430 Added 30.8%
1,826 $590 Million
Q1 2022

Feb 13, 2025

SELL
$234.69 - $291.66 $4,928 - $6,124
-21 Reduced 1.14%
1,829 $524 Million
Q4 2021

Feb 13, 2025

BUY
$224.85 - $279.04 $415,972 - $516,224
1,850 New
1,850 $511 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.